No more hypoglycaemia on days with physical activity and unrestricted diet when using a closed‐loop system for 12 weeks: A post‐hoc secondary analysis of the multicentre randomized controlled Diabeloop WP7 trial
| Title: | No more hypoglycaemia on days with physical activity and unrestricted diet when using a closed‐loop system for 12 weeks: A post‐hoc secondary analysis of the multicentre randomized controlled Diabeloop WP7 trial |
|---|---|
| Authors: | Franc, Sylvia; Benhamou, Pierre‐yves; Borot, Sophie; Chaillous, Lucy; Delemer, Brigitte; Doron, Maeva; Guerci, Bruno; Hanaire, Hélène; Huneker, Erik; Jeandidier, Nathalie; Amadou, Coralie; Renard, Eric; Reznik, Yves; Schaepelynck, Pauline; Simon, Chantal; Thivolet, Charles; Thomas, Claire; Hannaert, Patrick; Charpentier, Guillaume |
| Contributors: | Centre Hospitalier Sud Francilien - Centre Hospitalier d'Evry (CHSF); Laboratoire de Biologie de l'Exercice pour la Performance et la Santé (LBEPS); Service de Santé des Armées-Université d'Évry-Val-d'Essonne (UEVE)-Université Paris-Saclay-Institut de Recherche Biomédicale des Armées Brétigny-sur-Orge (IRBA); Centre d'études et de recherches pour l'intensification du traitement du diabète (CERITD); CHU de Grenoble-Alpes - Centre Hospitalier Universitaire CHU Grenoble (CHUGA); Service d'Hépatologie CHRU Besançon; Centre Hospitalier Régional Universitaire de Besançon (CHRU Besançon); Centre Hospitalier Universitaire de Nantes = Nantes University Hospital (CHU Nantes); Service d'Endocrinologie - Diabète - Nutrition Reims; Université de Reims Champagne-Ardenne (URCA)-Hôpital Robert Debré; Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital universitaire Robert Debré Reims (CHU Reims); Commissariat à l'énergie atomique et aux énergies alternatives - Laboratoire d'Electronique et de Technologie de l'Information (CEA-LETI); Direction de Recherche Technologique (CEA) (DRT (CEA)); Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA); Service d'Endocrinologie - Diabète - Nutrition CHRU Nancy; Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy); Service Diabétologie CHU Toulouse; Pôle Cardiovasculaire et Métabolique CHU Toulouse; Centre Hospitalier Universitaire de Toulouse (CHU Toulouse)-Centre Hospitalier Universitaire de Toulouse (CHU Toulouse); Diabeloop S.A.; Centre Hospitalier Universitaire Strasbourg (CHU Strasbourg); Hôpitaux Universitaires de Strasbourg (HUS); Université Paris-Saclay; Institut de Génomique Fonctionnelle (IGF); Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS); Centre Hospitalier Régional Universitaire Montpellier (CHRU Montpellier); Hôpital Côte de Nacre CHU Caen; CHU Caen Normandie – Centre Hospitalier Universitaire de Caen Normandie (CHU Caen Normandie); Normandie Université (NU)-Normandie Université (NU); Hôpital Sainte-Marguerite CHU - APHM (Hôpitaux Sud); Centre Hospitalier Lyon Sud CHU - HCL (CHLS); Hospices Civils de Lyon (HCL); Ischémie Reperfusion en Transplantation d’Organes Mécanismes et Innovations Thérapeutiques U 1082 (IRTOMIT Poitiers ); Université de Poitiers = University of Poitiers (UP)-Institut National de la Santé et de la Recherche Médicale (INSERM); Diabeloop SA; French Innovation Fund |
| Source: | ISSN: 1462-8902. |
| Publisher Information: | CCSD; Wiley |
| Publication Year: | 2021 |
| Collection: | Université de Reims Champagne-Ardenne: Archives Ouvertes (HAL) |
| Subject Terms: | Artificial pancreas; Closed-loop system; Continuous glucose monitoring; Glycaemic control; Hypoglycaemia; Insulin pump therapy; Physical activity; Physical intervention; Randomized controlled trial; Type 1 diabetes; [SDV.MHEP.EM]Life Sciences [q-bio]/Human health and pathology/Endocrinology and metabolism; [SDV.MHEP.PHY]Life Sciences [q-bio]/Human health and pathology/Tissues and Organs [q-bio.TO]; [SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie |
| Description: | Conflict of interests: SF declares congress invitations from Sanofi, Eli Lilly, MSD, Novo Nordisk, Roche, Abbott and Boehringer; she has received speaker honoraria from Lilly and Novo Nordisk, and served on advisory board panels for Novo Nordisk, Diabeloop, Roche, Sanofi, Janssen and Lifescan. She also owns shares in Diabeloop SA. PYB has received speaker honoraria from Abbott, Roche, Eli Lilly, Novo Nordisk and Sanofi, and has served on advisory board panels for Abbott, Diabeloop, Roche, Medtronic, Dexcom, Insulet, Lifescan, Eli Lilly, Novo Nordisk and Sanofi. SB has received personal compensation for board participation and speaking fees from Abbott, Eli Lilly, Novo Nordisk, Medtronic and Sanofi Aventis. LC has received personal compensation for board participation and speaking fees from Eli Lilly, Lifescan, Novo Nordisk, Roche Diagnostics, Medtronic and Sanofi Aventis. BD has received personal compensation for board participation and speaking fees from Eli Lilly, Novo Nordisk, Sanofi Aventis, MSD and Astra Zeneca. MD is employed by Univ. Grenoble Alpes, CEA LETI, F-38000 Grenoble. BG participated as an advisory panel/board member of Sanofi, Eli Lilly, NovoNordisk, Novartis, GSK, MSD, Boehringer Ingelheim, AstraZeneca, Abbott, Medtronic and Roche Diagnostics; he also participated as a clinical investigator for Sanofi, Eli Lilly, NovoNordisk, GSK, BMS, AstraZeneca, Medtronic, Abbott, Roche Diagnostics, MSD, Novartis, Janssen and Boehringer Ingelheim, and received research support from Medtronic, Vitalaire, Sanofi, Eli Lilly and Novo Nordisk. HH has received personal compensation for board participation and speaking fees from Abbott, Dexcom, Eli Lilly, Lifescan, Novo Nordisk, Roche Diagnostics, Medtronic, Sanofi Aventis and BD. EH is an employee of Diabeloop S.A. NJ received personal compensation for board participation and speaking fees from Eli Lilly, Novo Nordisk, Sanofi Aventis and Roche. CA has received congress invitations from Eli Lilly and AstraZeneca, and has received speaker honoraria from Diabeloop. ... |
| Document Type: | article in journal/newspaper |
| Language: | English |
| Relation: | info:eu-repo/semantics/altIdentifier/pmid/34009725; PUBMED: 34009725; PUBMEDCENTRAL: PMC8453744 |
| DOI: | 10.1111/dom.14442 |
| Availability: | https://hal.science/hal-03240584; https://hal.science/hal-03240584v1/document; https://hal.science/hal-03240584v1/file/DOM-23-2170.pdf; https://doi.org/10.1111/dom.14442 |
| Rights: | https://creativecommons.org/licenses/by-nc-nd/4.0/ ; info:eu-repo/semantics/OpenAccess |
| Accession Number: | edsbas.EDDBA8CD |
| Database: | BASE |